| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |